Scarica l'app Stockscreener
98.24
0.37%
0.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$97.89
Aprire:
$98.42
Volume 24 ore:
885.81K
Relative Volume:
0.38
Capitalizzazione di mercato:
$18.74B
Reddito:
$8.41B
Utile/perdita netta:
$760.80M
Rapporto P/E:
25.51
EPS:
3.8513
Flusso di cassa netto:
$1.05B
1 W Prestazione:
+1.08%
1M Prestazione:
+4.43%
6M Prestazione:
+1.87%
1 anno Prestazione:
-4.81%
Intervallo 1D:
$97.61
$100.06
Intervallo di 1 settimana:
$94.28
$100.06
Portata 52W:
$79.12
$108.29
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
98.24 | 18.67B | 8.41B | 760.80M | 1.05B | 3.8513 |
ABT
Abbott Laboratories
|
110.68 | 191.92B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
340.66 | 133.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.67 | 116.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.38 | 74.52B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.58 | 53.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| 2026-02-20 | Iniziato | William Blair | Mkt Perform |
| 2026-01-09 | Downgrade | Goldman | Neutral → Sell |
| 2026-01-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Will Zimmer Biomet’s Upgraded 2026 Guidance and Buyback Shift Zimmer Biomet Holdings’ (ZBH) Narrative - simplywall.st
Zimmer Biomet reports strong second quarter financial results - Today's Medical Developments
Donald TrumpZIMMER BIOMET HOLDINGS INC Trump Trade on May. 11, 2026 - Quiver Quantitative
Zimmer Biomet (ZBH): Capital International Investors reports 6.4% ownership stake - Stock Titan
Assenagon Asset Management S.A. Buys 97,887 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet (NYSE:ZBH) Price Target Raised to $100.00 - MarketBeat
Price to earnings forward of Zimmer Biomet Holdings, Inc. – NYSE:ZBH - TradingView
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Strong Potential Upside with Robust Analyst Ratings - directorstalkinterviews.com
Zimmer Biomet Q2 Earnings Call Highlights - Yahoo Finance
Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Q2 2026 Zimmer Biomet Holdings, Inc Earnings Call Transcript - GuruFocus
Wall Street Zen Downgrades Zimmer Biomet (NYSE:ZBH) to Hold - MarketBeat
Wells Fargo Adjusts Price Target on Zimmer Biomet to $103 From $90 - Moomoo
Wilsey Asset Management Inc. Has $36.32 Million Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Truist Adjusts Price Target on Zimmer Biomet to $106 From $92, Maintains Hold Rating - marketscreener.com
Zimmer Biomet Holdings (ZBH) Following Its Beat And Guidance Lift, Is The Valuation Catching Up? - Yahoo Finance
Zimmer Biomet (ZBH) Stock Gets Fair Value Bump After Mixed Analyst Views - Yahoo Finance
Zimmer Biomet Holdings, Inc. (ZBH) Stock forecasts - Yahoo Finance Singapore
Baird Adjusts Zimmer Biomet Price Target to $104 From $92 - Moomoo
Zimmer Biomet Holdings (ZBH) Gets a Buy from TD Cowen - The Globe and Mail
RBC Capital Adjusts Price Target on Zimmer Biomet to $110 From $101, Maintains Outperform Rating - Moomoo
Bernstein Adjusts Price Target on Zimmer Biomet to $93 From $91 - marketscreener.com
Zimmer Biomet Holdings, Inc. Stock 12‑Month Price Target Raised to $104.9, Implies 7% Upside - TradingView
Leerink Partners Adjusts Price Target on Zimmer Biomet to $106 From $90 - marketscreener.com
JPMorgan Adjusts Price Target on Zimmer Biomet to $117 From $95 - marketscreener.com
UBS Adjusts Price Target on Zimmer Biomet to $120 From $115, Maintains Buy Rating - marketscreener.com
Deutsche Bank Adjusts Zimmer Biomet Price Target to $98 From $88, Maintains Hold Rating - marketscreener.com
Zimmer Biomet sales force revamp going better than expected, CEO says - Yahoo Finance
Renaissance Technologies LLC Invests $5.47 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Needham reiterates Hold on Zimmer Biomet stock after Q2 beat By Investing.com - Investing.com Nigeria
Bank of America Corp DE Purchases 249,175 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
ZIMMER BIOMET HOLDINGS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $106.00 FROM $90.00 - Bitget
Zimmer Biomet Holdings, Inc. : Leerink Partne - Moomoo
Zimmer Biomet Holdings, Inc. Stock 12‑Month Price Target Raised to $99.58, Implies 4% Upside - TradingView
Zimmer Biomet Holdings Inc (ZBH) (Q2 2026) Earnings Call Highlights: Strong Sales Beat and ... - Yahoo Finance
Zimmer Biomet Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Zimmer Biomet (NYSE: ZBH) awards 10,168 RSUs to President, APAC - Stock Titan
Zimmer Biomet (NYSE: ZBH) lifts Q2 2026 earnings and cash flow - Stock Titan
Tranche Update on Zimmer Biomet Holdings, Inc.'s Equity Buyback Plan announced on February 10, 2026. - marketscreener.com
Needham reiterates Hold on Zimmer Biomet stock after Q2 beat - Investing.com
Baird Adjusts Price Target on Zimmer Biomet to $104 From $92, Maintains Neutral Rating - moomoo.com
Earnings call transcript: Zimmer Biomet lifts 2026 outlook after Q2 beat - Investing.com
Why is Zimmer Biomet stock surging today? - Investing.com
Zimmer Biomet raises full-year outlook after second-quarter earnings beat - Yahoo Finance
Zimmer Biomet Holdings Inc. R (ZIM.HA) Q2 FY2026 earnings call transcript - Yahoo Finance
Royal Bank of Canada Sells 86,837 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (ZBH) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Zimmer Biomet earnings beat by $0.06, revenue topped estimates - Investing.com
Zimmer Biomet stock rises 4% on Q2 beats, raised guidance - Investing.com
Zimmer Biomet Q2 Adjusted Earnings Flat, Net Sales Rise; Lifts 2026 Guidance - Yahoo Finance
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.82%
1.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):